FDA: B Braun Medical recalls one lot of 5% Dextrose Injection
Editor's Note
The Food and Drug Administration on March 29 announced the recall by B Braun Medical (Bethlehem, Pennsylvania) of one lot of 5% Dextrose Injection USP 100/150 mL container (Lot #J5J706, catalog #S5104-5264, NDC -1510-32).
The company received customer complaints that some containers exhibited leakage and, in a few instances, visible particulate matter identified as microbial growth.
Posted 03/29/2016] AUDIENCE: Pharmacy, Nursing ISSUE: B. Braun Medical Inc. is recalling one lot of 5% Dextrose Injection USP 100/150mL container (Lot #J5J706, catalog #S5104-5264, NDC 0264-1510-32) to the consumer level. B. Braun recently identified an adverse quality trend in customer complaints reporting that some containers in lot J5J706 exhibited leakage and, in a few instances, visible particulate matter identified to be microbial growth.
Read More >>
Free Daily News
- HCA Healthcare reports solid first-quarter financials
- Per-person healthcare spending grows nearly 19% in 5 years
- OR Manager Conference: Lowest rates expire in one week
- Hospitals boost cybersecurity budgets, staff
- Kentucky passes first-ever state law decriminalizing medical mistakes
- Kaiser Permanente data breach affects 13.4 million
- Study explores link between diverticulitis and colorectal cancer
- State lawmakers target rising healthcare costs via legislation on hospital facility fees
- FDA medical device Class 1 recalls trend upward
- Data cast doubt on recommendation to delay weight-loss meds prior to surgery